Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 38% ± 21% | |
| neuron | 4 studies | 27% ± 9% | |
| retinal ganglion cell | 4 studies | 54% ± 28% | |
| endothelial cell | 3 studies | 20% ± 3% | |
| GABAergic neuron | 3 studies | 41% ± 10% | |
| oligodendrocyte | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 31% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1935.68 | 2642 / 2642 | 100% | 38.15 | 704 / 705 |
| prostate | 97% | 442.97 | 238 / 245 | 79% | 4.53 | 396 / 502 |
| ovary | 100% | 601.41 | 180 / 180 | 66% | 2.91 | 284 / 430 |
| thymus | 64% | 149.88 | 418 / 653 | 88% | 6.86 | 531 / 605 |
| kidney | 67% | 235.67 | 60 / 89 | 84% | 6.09 | 757 / 901 |
| stomach | 95% | 317.46 | 342 / 359 | 51% | 3.61 | 145 / 286 |
| breast | 72% | 241.69 | 331 / 459 | 73% | 5.08 | 811 / 1118 |
| intestine | 84% | 291.98 | 815 / 966 | 57% | 4.02 | 300 / 527 |
| adrenal gland | 57% | 145.53 | 147 / 258 | 81% | 17.58 | 186 / 230 |
| uterus | 99% | 499.86 | 168 / 170 | 35% | 2.01 | 161 / 459 |
| bladder | 76% | 194.05 | 16 / 21 | 48% | 2.86 | 243 / 504 |
| lung | 61% | 153.02 | 350 / 578 | 51% | 2.24 | 591 / 1155 |
| skin | 27% | 67.77 | 493 / 1809 | 71% | 5.21 | 333 / 472 |
| pancreas | 6% | 13.32 | 20 / 328 | 90% | 6.78 | 160 / 178 |
| blood vessel | 93% | 335.56 | 1241 / 1335 | 0% | 0 | 0 / 0 |
| liver | 39% | 85.84 | 88 / 226 | 54% | 2.71 | 218 / 406 |
| esophagus | 63% | 263.95 | 910 / 1445 | 28% | 1.16 | 52 / 183 |
| heart | 91% | 436.88 | 786 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 3.89 | 21 / 29 |
| adipose | 47% | 111.79 | 562 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 35% | 2.18 | 28 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.26 | 4 / 45 |
| muscle | 6% | 11.80 | 45 / 803 | 0% | 0 | 0 / 0 |
| spleen | 2% | 3.30 | 4 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SERP2 |
| Protein name | Stress-associated endoplasmic reticulum protein 2 (Ribosome-associated membrane protein RAMP4-2) Stress-associated endoplasmic reticulum protein Stress associated endoplasmic reticulum protein family member 2 |
| Synonyms | C13orf21 |
| Description | FUNCTION: Interacts with target proteins during their translocation into the lumen of the endoplasmic reticulum. Protects unfolded target proteins against degradation during ER stress. May facilitate glycosylation of target proteins after termination of ER stress. May modulate the use of N-glycosylation sites on target proteins. . FUNCTION: Interacts with target proteins during their translocation into the lumen of the endoplasmic reticulum. Protects unfolded target proteins against degradation during ER stress. May facilitate glycosylation of target proteins after termination of ER stress. May modulate the use of N-glycosylation sites on target proteins. .; FUNCTION: Interacts with target proteins during translocation into the lumen of the endoplasmic reticulum. Protects unfolded target proteins against degradation and facilitate correct glycosylation. . FUNCTION: Interacts with target proteins during their translocation into the lumen of the endoplasmic reticulum. Protects unfolded target proteins against degradation during ER stress. May facilitate glycosylation of target proteins after termination of ER stress. May modulate the use of N-glycosylation sites on target proteins. .; FUNCTION: Interacts with target proteins during translocation into the lumen of the endoplasmic reticulum. Protects unfolded target proteins against degradation and facilitate correct glycosylation. . |
| Accessions | H7C5W3 ENST00000379179.8 F2Z2S5 A0A087WTA6 ENST00000493476.1 ENST00000474333.5 Q8N6R1 ENST00000616650.1 |
